View Cart  

U.S. FDA Plans Guidance on Device Enhancement versus Recall

A A
The U.S. Food and Drug Administration (FDA) plans to issue clarifying guidance to address confusion among devicemakers about what exactly constitutes an enhancement and what qualifies as a recall, an FDA official says.

To View This Article:

Login

Subscribe To International Medical Device Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00